Seizert Capital Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-102,375
| Closed | -$3.18M | – | 187 |
|
|
2022
Q2 | $3.18M | Buy |
102,375
+38,859
| +61% | +$1.21M | 0.17% | 95 |
|
|
2022
Q1 | $2.61M | Buy |
63,516
+51
| +0.1% | +$2.09K | 0.12% | 108 |
|
|
2021
Q4 | $2.76M | Buy |
63,465
+1,611
| +3% | +$70K | 0.12% | 108 |
|
|
2021
Q3 | $3.1M | Buy |
61,854
+36,047
| +140% | +$1.8M | 0.14% | 104 |
|
|
2021
Q2 | $1.63M | Buy |
+25,807
| New | +$1.63M | 0.08% | 119 |
|
|
2017
Q1 | – | Sell |
-102,413
| Closed | -$3.36M | – | 221 |
|
|
2016
Q4 | $3.36M | Buy |
102,413
+411
| +0.4% | +$13.5K | 0.12% | 99 |
|
|
2016
Q3 | $3.22M | Sell |
102,002
-7,512
| -7% | -$237K | 0.12% | 97 |
|
|
2016
Q2 | $3.08M | Buy |
109,514
+6,580
| +6% | +$185K | 0.12% | 98 |
|
|
2016
Q1 | $3.74M | Buy |
102,934
+29,222
| +40% | +$1.06M | 0.13% | 97 |
|
|
2015
Q4 | $2.95M | Sell |
73,712
-21,808
| -23% | -$872K | 0.09% | 122 |
|
|
2015
Q3 | $2.72M | Sell |
95,520
-13,003
| -12% | -$370K | 0.08% | 125 |
|
|
2015
Q2 | $3.58M | Sell |
108,523
-54,203
| -33% | -$1.79M | 0.09% | 120 |
|
|
2015
Q1 | $4.68M | Sell |
162,726
-75,590
| -32% | -$2.17M | 0.12% | 107 |
|
|
2014
Q4 | $6.49M | Sell |
238,316
-12,819
| -5% | -$349K | 0.14% | 87 |
|
|
2014
Q3 | $5.35M | Buy |
251,135
+89,965
| +56% | +$1.92M | 0.11% | 99 |
|
|
2014
Q2 | $3.62M | Buy |
161,170
+106,126
| +193% | +$2.38M | 0.07% | 121 |
|
|
2014
Q1 | $1.39M | Buy |
55,044
+4,547
| +9% | +$115K | 0.03% | 120 |
|
|
2013
Q4 | $1.16M | Sell |
50,497
-28,015
| -36% | -$644K | 0.03% | 128 |
|
|
2013
Q3 | $1.5M | Buy |
78,512
+6,170
| +9% | +$118K | 0.04% | 90 |
|
|
2013
Q2 | $1.04M | Buy |
+72,342
| New | +$1.04M | 0.03% | 107 |
|